The chimeric protein BCR-ABL1 was previously shown to drive neoplastic transformation of hematopoietic stem cells in chronic myelogenous leukemia [32]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.